Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...

As of late October, the CDC recommends a second dose of the 2024-2025 COVID-19 vaccine for at-risk groups. Here's what you ...

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...

The issue of vaccine injury compensation has received increased scrutiny since the pandemic. While the vaccines approved for ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

With respiratory illness season underway, the New York State Department of Health is actively urging residents aged 6 months ...

A Kingston, Ont., doctor celebrated for organizing drive-thru vaccination clinics that helped thousands get shots at the ...

The biotech company, which makes the Spikevax RNA-based Covid-19 vaccine, reported net income of $13 million, or 3 cents a share, compared with a loss of $3.6 billion, or $9.53 a share, in the same ...

A study conducted by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the ...

Older Americans are being urged to get the COVID-19 vaccine again, but it depends on when they received their last dose.

The Centers for Disease Control and Prevention's (CDC's) 2024-2025 COVID-19 vaccine immunization schedule advises, in the ...

Refusal of COVID-19 and influenza vaccinations was higher among White patients at an allergy/immunology clinic with a diverse ...